LivaNova Raises Full-Year Earnings and Revenue-Growth Projections
The medical-technology maker lifted its adjusted earnings and revenue-growth projections for the year. Its shares rose 12% to $89.94 premarket Wednesday.
By Rob CurranLivaNova shares rose after the maker of medical technology boosted its adjusted earnings and revenue-growth projections for the year.Shares of LivaNova rose 12% to $89.94, premarket on Wednesday.The Gloucester, U.K. medical-device maker posted earnings of $34.3 million, or 11 cents a s…